EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor

Hai Le Thanh Nguyen iD, Ge Peng iD, Juan Valentin Trujillo-Paez, Hainan Yue, Risa Ikutama, Miho Takahashi, Yoshie Umehara, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda, François Niyonsaba iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hai Le Thanh Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Juntendo University, Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, National Eczema Association Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimicrobial peptide derived from insulin-like growth factor-binding protein 5 (AMP-IBP5) exhibits antimicrobial activities and immunomodulatory functions in keratinocytes and fibroblasts. However, its role in regulating skin barrier function remains unclear. Here, we investigated the effects of AMP-IBP5 on the skin barrier and its role in the pathogenesis of atopic dermatitis (AD). 2,4-Dinitrochlorobenzene was used to induce AD-like skin inflammation. Transepithelial electrical resistance and permeability assays were used to investigate tight junction (TJ) barrier function in normal human epidermal keratinocytes and mice. AMP-IBP5 increased the expression of TJ-related proteins and their distribution along the intercellular borders. AMP-IBP5 also improved TJ barrier function through activation of the atypical protein kinase C and Rac1 pathways. In AD mice, AMP-IBP5 ameliorated dermatitis-like symptoms restored the expression of TJ-related proteins, suppressed the expression of inflammatory and pruritic cytokines, and improved skin barrier function. Interestingly, the ability of AMP-IBP5 to alleviate inflammation and improve skin barrier function in AD mice was abolished in mice treated with an antagonist of the low-density lipoprotein receptor-related protein-1 (LRP1) receptor. Collectively, these findings indicate that AMP-IBP5 may ameliorate AD-like inflammation and enhance skin barrier function through LRP1, suggesting a possible role for AMP-IBP5 in the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansAnimalsMiceAntimicrobial PeptidesKeratinocytesInflammationCytokinesDisease Models, AnimalLipoproteins, LDLSkin

Stichwörter der Autor:innen

AMP-IBP5antimicrobial peptideatopic dermatitisbarrier functionskin barrier

Substanzen

Antimicrobial PeptidesCytokinesLipoproteins, LDL

Autor:innen und Institutionen

  • Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Faculty of International Liberal Arts, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

ORCID-Profile: Hai Le Thanh Nguyen, Ge Peng, François Niyonsaba

Förderung

  • Juntendo University
  • Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan
  • National Eczema Association Research Grant
  • Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan

Zitieren

APA

Nguyen, H. L. T., Peng, G., Trujillo-Paez, J. V., Yue, H., Ikutama, R., Takahashi, M., Umehara, Y., Okumura, K., Ogawa, H., Ikeda, S., & Niyonsaba, F. (2023). The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065200

Vancouver

Nguyen HLT, Peng G, Trujillo-Paez JV, Yue H, Ikutama R, Takahashi M, et al. The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065200

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Hai Le Thanh and Peng, Ge and Trujillo-Paez, Juan Valentin and Yue, Hainan and Ikutama, Risa and Takahashi, Miho and Umehara, Yoshie and Okumura, Ko and Ogawa, Hideoki and Ikeda, Shigaku and Niyonsaba, François},
  title = {The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065200}
}
Kostenlos starten →